<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146271">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01196377</url>
  </required_header>
  <id_info>
    <org_study_id>100725</org_study_id>
    <secondary_id>K23HL080005</secondary_id>
    <nct_id>NCT01196377</nct_id>
  </id_info>
  <brief_title>Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study</brief_title>
  <acronym>OARS</acronym>
  <official_title>Personalized Medicine, Biomarker-based Study of Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our overall objective is to model a pediatric Acute Asthma Clinical Decision Rule (ADR) for
      personalized medicine by identification of treatment-response phenotypes that are important
      determinants of outcome. The Specific Aim of this study is to determine the feasibility of
      this approach by enrolling a pilot cohort of 16 participants in this DBRCT of 4 different
      albuterol treatment regimens, 2 of which will use 10mg/hr and 2 of which will use 25mg/hr.
      Within these dosages there will be a pulsed-treatment regimen and a continuous regimen.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FEV1</measure>
    <time_frame>0, 40, 80 and 120 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Moderate and Severe Acute Asthma Exacerbations in Pediatric Patients</condition>
  <arm_group>
    <arm_group_label>Nebulized albuterol 10mg/hr continuous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active control arm, 10mg/hr continuous.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10mg/hr pulsed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental 10mg/hr pulsed albuterol regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>25mg/hr continuous</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental 25mg/hr continuous albuterol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>25mg/hr pulsed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental 25mg/hr pulsed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albuterol</intervention_name>
    <description>Nebulized albuterol</description>
    <arm_group_label>Nebulized albuterol 10mg/hr continuous</arm_group_label>
    <arm_group_label>10mg/hr pulsed</arm_group_label>
    <arm_group_label>25mg/hr continuous</arm_group_label>
    <arm_group_label>25mg/hr pulsed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Doctor diagnosed asthma

          -  Acute asthma exacerbation

          -  Treatment with systemic corticosteroids and nebulized albuterol

          -  Ages 5 to 17 years

        Exclusion Criteria:

          -  Other acute or chronic lung disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald H Arnold, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University School of Medicine</affiliation>
  </overall_official>
  <verification_date>June 2012</verification_date>
  <lastchanged_date>June 19, 2012</lastchanged_date>
  <firstreceived_date>September 3, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Donald H Arnold</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics and Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Acute asthma</keyword>
  <keyword>Pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Status Asthmaticus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Albuterol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
